News

A recent study evaluated the advantages and limitations of various noninvasive imaging modalities in diagnosing cardiovascular disease (CVD) in patients with autoimmune rheumatic diseases (ARDs).

Recent advancements in artificial intelligence (AI) are reshaping dermatology, particularly in diagnosing skin diseases like skin cancer.

Emerging research highlights critical windows of susceptibility to lead exposure that may reduce antibody responses to childhood vaccines, raising concerns for immune health.

A machine learning model, SCORPIO, has shown promise in predicting the success of immune checkpoint inhibitors (ICIs) for patients with cancer.

A new randomized clinical trial suggests that once-weekly semaglutide may help reduce alcohol consumption and cravings in adults with alcohol use disorder (AUD).

The National Institutes of Health (NIH) faces substantial funding cuts that could derail progress in critical medical research.

Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may significantly reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with type 2 diabetes (T2D), according to a large U.S.-based study.

Antibiotic-resistant Escherichia coli and Klebsiella pneumoniae are major causes of urinary tract infections (UTIs) and vaginal inflammation, posing a growing health challenge worldwide.